Literature DB >> 26838260

Impact of Time Interval Between Chemoradiation and Surgery on Pathological Complete Response and Survival in Rectal Cancer.

Ali Akbar1, Abu Bakar Hafeez Bhatti, Samiullah Khan Niazi, Amir Ali Syed, Shahid Khattak, Syed Hassan Raza, Ather Saeed Kazmi.   

Abstract

BACKGROUND: Limited data are available regarding the impact of time duration between chemoradiation (CRT) and surgery on pathological complete response (PCR). A PCR translates into better overall and disease free survival. The objective of this study was to determine effect of time duration on outcome after preoperative CRT in rectal cancer.
MATERIALS AND METHODS: A retrospective review of patients undergoing operations for rectal adenocarcinoma between January 2005 and December 2010 was performed. Patients were divided in two groups: Group 1 underwent surgery in ≤ 8weeks post neoadjuvant CRT and Group 2 after 8 weeks. Patient characteristics, surgical procedure, histopathological details and number of loco-regional and distant failures were compared. Expected 5 year overall survival and disease free survival was calculated using Kaplan Meier curves and significance was determined using the log rank test.
RESULTS: There were 66 patients in group 1 and 93 in group 2. No significant difference in PCR was observed between the two. However, estimated 5 year DFS was significantly higher in Group 1 (66.7%) as compared to Group 2 (53.8%) (P=0.04). Estimated overall 5 year overall survival was not significantly different at 68.2% versus 54.3% (P= 0.09).
CONCLUSIONS: Delaying surgery more than 8 weeks after preoperative CRT does not impact for PCR in rectal cancer.

Entities:  

Mesh:

Year:  2016        PMID: 26838260     DOI: 10.7314/apjcp.2016.17.1.89

Source DB:  PubMed          Journal:  Asian Pac J Cancer Prev        ISSN: 1513-7368


  4 in total

1.  Does a long interval between neoadjuvant chemoradiotherapy and surgery benefit the clinical outcomes of locally advanced rectal cancer? A systematic review and meta analyses.

Authors:  Miao Yu; Deng-Chao Wang; Sheng Li; Li-Yan Huang; Jian Wei
Journal:  Int J Colorectal Dis       Date:  2022-03-12       Impact factor: 2.571

2.  Gastrointestinal Malignancies and the COVID-19 Pandemic: Evidence-Based Triage to Surgery.

Authors:  Scott C Fligor; Sophie Wang; Benjamin G Allar; Savas T Tsikis; Ana Sofia Ore; Ashlyn E Whitlock; Rodrigo Calvillo-Ortiz; Kevin R Arndt; Sidhu P Gangadharan; Mark P Callery
Journal:  J Gastrointest Surg       Date:  2020-06-30       Impact factor: 3.452

3.  Cross-Sectional Study on MRI Restaging After Chemoradiotherapy and Interval to Surgery in Rectal Cancer: Influence on Short- and Long-Term Outcomes.

Authors:  Robin Detering; Wernard A A Borstlap; Lisa Broeders; Linda Hermus; Corrie A M Marijnen; Regina G H Beets-Tan; Willem A Bemelman; Henderik L van Westreenen; Pieter J Tanis
Journal:  Ann Surg Oncol       Date:  2018-12-13       Impact factor: 5.344

4.  Temporal determinants of tumour response to neoadjuvant rectal radiotherapy.

Authors:  Kendrick Koo; Rachel Ward; Ryan L Smith; Jeremy Ruben; Peter W G Carne; Hany Elsaleh
Journal:  PLoS One       Date:  2021-06-30       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.